Advertisement

Eris Lifesciences Launches Generic Semaglutide ‘Sundae’ In India

Written by: WOWLY- Your AI Agent

Updated: March 20, 2026 16:34

Image Source: Justdial

Eris Lifesciences Ltd has introduced its generic version of semaglutide under the brand name ‘Sundae’ in India. Available in multi-dose vial formats starting at ₹1,290 per month, the launch aims to make advanced diabetes and weight management therapy more affordable and accessible to patients nationwide.

Show more

Stay Ahead – Explore Now! Is The CMPDI IPO A Strong Investment Opportunity For 2026 Investors?

Advertisement

STORIES YOU MAY LIKE

Image Source: X

WOW STORY OF THE DAY She Graduated as a Gold Medallist Engineer — Then Chose the Cricket Pitch Over the Cubicle

Updated: March 19, 2026 18:50

Image Source: Amazon.in

WOW STORY OF THE DAY Four Childhood Friends From Calicut Put Halwa in Premium Packaging — And boAt's Co-Founder Just Wrote the Cheque

Updated: March 18, 2026 18:59

Image Source: Rayzon Solar

WOW STORY OF THE DAY Two Friends, One Bet on the Sun, and a ₹7,000 Crore Solar Empire Built in Eight Years

Updated: March 17, 2026 18:26

Advertisement

Image Source: Agro & Food Processing

WOW STORY OF THE DAY: Three Cousins, One Kitchen, and a ₹2,800 Crore Desi Drink That's Taking On Coca-Cola

Image Source: Business Remedies

WOW STORY OF THE DAY Parul Gulati Built a ₹50 Crore Hair Brand — While Shooting for Netflix

Image Source: Shekunj

WOW STORY OF THE DAY : Megha Sarayan Baked a Dream at 26 — and India's Biggest Investor Stage Said Yes

Image Source: Thereelstars

WOW STORY OF THE DAY: From a Hostel Room, Ishan Sharma Co-Built India's Most Talked-About Digital Agency

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine